Crispr Therapeutics shares owned by Capital International Sarl
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital International Sarl
from 13F filings
Historical chart of Capital International Sarl investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Capital International Sarl consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Capital International Sarl
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $4.2M | 92k | 45.39 |
| 2023-06-30 | $4.8M | 85k | 56.14 |
| 2023-03-31 | $3.5M | 77k | 45.23 |
| 2022-12-31 | $2.4M | 59k | 40.65 |
| 2022-09-30 | $3.3M | 50k | 65.35 |
| 2022-06-30 | $1.9M | 31k | 60.78 |
| 2022-03-31 | $1.5M | 24k | 62.76 |
| 2021-12-31 | $1.5M | 20k | 75.79 |
| 2021-09-30 | $440k | 3.9k | 112.02 |
| 2021-06-30 | $680k | 4.2k | 161.83 |
| 2021-03-31 | $727k | 6.0k | 121.82 |
| 2020-12-31 | $1.6M | 10k | 153.11 |
| 2020-09-30 | $793k | 9.5k | 83.61 |
More positions owned by Capital International Sarl
View all positions for Capital International Sarl